Ten Bio News
The origins of TenSkin™
Entering our third year since spin out, it’s time to celebrate the origins of our technology which has brought Ten Bio early success in a
‘When I was two, I was nearly new’ ….
‘When I was two I was nearly new’ … with thanks to A. A. Milne for the line from his 1927 poem ‘Now we are
Our differentiation in wound management….
In the previous note from the chairman I emphasized the potential role for Ten Bio in the area of wound management. My reason for that
Dr Paul Campbell seconded to Ten Bio through UK Medical Research Council Innovation Scholarship
Dr Paul Campbell, Reader in Physics at the University of Dundee has recently begun a secondment to Ten Bio through an Innovation Scholarship funded by the UK’s Medical Research Council.
Proud to be presenting at the Society for Investigative Dermatology Annual Meeting in Portland
May 18-21, 2022 We are proud to be exhibiting and presenting at the Society for Investigative Dermatology annual meeting later this week. Our Founder and
It’s just the start of Ten Bio’s journey…
A note from the Chair. I was introduced to Ten Bio’s founders in November 2019. I was immediately engaged by two things: firstly, the logic
Investment enables Ten Bio to establish new skin testing technology in USA
A near-£1 million investment will help University of Dundee spinout company Ten Bio Ltd to commercialise the human skin culture system it developed to provide
TenSkin used to show effects of filtered far-UVC radiation in skin
Ten Bio’s innovative human skin model, TenSkinTM, features in a recent publication assessing the carcinogenic risk through direct DNA damage of filtered far-UVC exposure. This
Ten Bio win at Scottish Edge
Ten Bio Ltd has won £65,000 in a national competition supporting Scotland’s most exciting new enterprises. Scottish EDGE is the UK’s largest business funding competition,
Converge Challenge prize for Ten Bio
Dr Hickerson was last night named runner-up in the Converge Challenge category of Converge 2020, receiving £29,000 in cash and in-kind business support. Converge is
Advances and Opportunities in (Pre)Clinical Testing for Cosmetics and Personal Care
We are pleased to share this Global Perspectives Column in EURO COSMETICS Mag written by Deanna Utroske. Ten Bio emphasises scientific discipline and rigour in all of our
Scientific Conferences R Ten Bio
Since Ten Bio launched in the autumn of 2020 our attendance at conferences, symposia etc. has been the central plank to our market engagement strategy.
TenSkin™– its role in reducing animal testing in skin research.
TenSkinᵀᴹ – its role in reducing animal testing in skin research. Generate more predictive preclinical data without animal testing.
Mechanical tension influences the immunocompetency of ex vivo skin tissue
Human-relevant testing methods using donated skin tissue offer a promising alternative to animal models. Our ex vivo culture system restores physiological tension in skin, preserving structure, function, and immune cells like Langerhans cells, enabling immune activation studies for up to seven days.
TenSkin™ – The perfect platform for microneedle applications.
Dr Paul Campbell gives his perspective on potential research avenues with TenSkin™. ‘Having worked directly with the company whilst on secondment over the past year,
Ten Bio is in Japan!
Ten Bio 社は日本にあります. In May this year, Ten Bio will attend the global session of the International Societies for Investigative Dermatology (ISID) to be held